Rhythm Pharmaceuticals Inc (RYTM) — Long-term Investment Intensity
Rhythm Pharmaceuticals Inc (RYTM) has a Long-term Investment Intensity of 5.0% as of June 2023. Long-term investments of $15.52 Million represent 5.0% of total assets of $309.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check RYTM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Rhythm Pharmaceuticals Inc Long-term Investment Intensity (2015–2022)
This chart shows how Rhythm Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2022. As of June 2023, the intensity stands at 5.0%, reflecting long-term investments of $15.52 Million against total assets of $309.94 Million USD. For the complete balance sheet picture, see Rhythm Pharmaceuticals Inc (RYTM) total assets.
Annual Long-term Investment Intensity for Rhythm Pharmaceuticals Inc (2015–2022)
The table below presents the year-by-year Long-term Investment Intensity for Rhythm Pharmaceuticals Inc from 2015 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Rhythm Pharmaceuticals Inc (RYTM) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 4.4% | $16.66 Million | $382.48 Million | ▲ +0.8 pp |
| 2021 | 3.6% | $11.81 Million | $329.52 Million | ▲ +3.4 pp |
| 2015 | 0.2% | $60.00K | $37.27 Million | — |